GIA
GMED icon

Gateway Investment Advisers’s Globus Medical GMED Stock Holding History

Gateway Investment Advisers’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$449K Buy
+5,211
New +$468K 0.01% 516

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gateway Investment Advisers's GMED Position: Q1 2026 in Review

Gateway Investment Advisers opened a new position in Globus Medical (GMED) in Q1 2026: 5,211 shares worth $449K. The stake represents 0.01% of the portfolio and ranks #516 among its holdings.

602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Gateway Investment Advisers held 5,211 shares of Globus Medical worth $449K as of Q1 2026.
  • Globus Medical was a new Gateway Investment Advisers position in Q1 2026.
  • Globus Medical made up 0.01% of Gateway Investment Advisers's portfolio in Q1 2026, its #516 holding.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Gateway Investment Advisers's 13F filing for Q1 2026, filed 13 Apr 2026.